Jeffrey S. Parkin

Array ( [id] => 4103815 [patent_doc_number] => 06056963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Immunogenic compositions comprising glycosylated and deglycosylated monomeric and dimeric forms of HIV-2 enveloped glycoproteins' [patent_app_type] => 1 [patent_app_number] => 8/477596 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 13092 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/056/06056963.pdf [firstpage_image] =>[orig_patent_app_number] => 477596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22791 [patent_doc_number] => 07794725 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-09-14 [patent_title] => 'Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains' [patent_app_type] => utility [patent_app_number] => 08/484223 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 35023 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794725.pdf [firstpage_image] =>[orig_patent_app_number] => 08484223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 961005 [patent_doc_number] => 06951717 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-04 [patent_title] => 'Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission' [patent_app_type] => utility [patent_app_number] => 08/484741 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 93 [patent_figures_cnt] => 94 [patent_no_of_words] => 201591 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951717.pdf [firstpage_image] =>[orig_patent_app_number] => 08484741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4338627 [patent_doc_number] => 06284248 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants' [patent_app_type] => 1 [patent_app_number] => 8/472240 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26522 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284248.pdf [firstpage_image] =>[orig_patent_app_number] => 472240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234686 [patent_doc_number] => 06080408 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles' [patent_app_type] => 1 [patent_app_number] => 8/482810 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11138 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080408.pdf [firstpage_image] =>[orig_patent_app_number] => 482810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640444 [patent_doc_number] => 06395469 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Inactivated respiratory syncytial viral vaccines' [patent_app_type] => B1 [patent_app_number] => 08/472174 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7528 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395469.pdf [firstpage_image] =>[orig_patent_app_number] => 08472174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22791 [patent_doc_number] => 07794725 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-09-14 [patent_title] => 'Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains' [patent_app_type] => utility [patent_app_number] => 08/484223 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 83 [patent_figures_cnt] => 84 [patent_no_of_words] => 35023 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794725.pdf [firstpage_image] =>[orig_patent_app_number] => 08484223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4096489 [patent_doc_number] => 06048685 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies' [patent_app_type] => 1 [patent_app_number] => 8/466706 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7255 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048685.pdf [firstpage_image] =>[orig_patent_app_number] => 466706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406730 [patent_doc_number] => 06265149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies' [patent_app_type] => 1 [patent_app_number] => 8/470491 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 17000 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265149.pdf [firstpage_image] =>[orig_patent_app_number] => 470491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1436145 [patent_doc_number] => 06355789 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'CLONED DNA SEQUENCES RELATED TO THE ENTIRE GENOMIC RNA OF HUMAN IMMUNODEFICIENCY VIRUS II (HIV-2), POLYPEPTIDES ENCODED BY THESE DNA SEQUENCES AND USE OF THESE DNA CLONES AND POLYPEPTIDES IN DIAGNOSTIC KITS' [patent_app_type] => B1 [patent_app_number] => 08/468424 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7053 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355789.pdf [firstpage_image] =>[orig_patent_app_number] => 08468424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3818657 [patent_doc_number] => 05770703 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene' [patent_app_type] => 1 [patent_app_number] => 8/468774 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 6307 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770703.pdf [firstpage_image] =>[orig_patent_app_number] => 468774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4176972 [patent_doc_number] => 06037165 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby' [patent_app_type] => 1 [patent_app_number] => 8/470487 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 17360 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037165.pdf [firstpage_image] =>[orig_patent_app_number] => 470487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1296698 [patent_doc_number] => 06627395 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-30 [patent_title] => 'Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1)' [patent_app_type] => B1 [patent_app_number] => 08/466256 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5666 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627395.pdf [firstpage_image] =>[orig_patent_app_number] => 08466256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4308096 [patent_doc_number] => 06316183 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)' [patent_app_type] => 1 [patent_app_number] => 8/467161 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 6956 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316183.pdf [firstpage_image] =>[orig_patent_app_number] => 467161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7595448 [patent_doc_number] => 07626013 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-12-01 [patent_title] => 'HIV-1 DNA fragments that hybridize to genomic HIV-1DNA' [patent_app_type] => utility [patent_app_number] => 08/466921 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4853 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/626/07626013.pdf [firstpage_image] =>[orig_patent_app_number] => 08466921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871605 [patent_doc_number] => 05824482 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Purification, cloning, and characterization of a novel human immunodeficiency virus LAV.sub.MAL' [patent_app_type] => 1 [patent_app_number] => 8/471474 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 12457 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824482.pdf [firstpage_image] =>[orig_patent_app_number] => 471474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3992538 [patent_doc_number] => 05985641 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies' [patent_app_type] => 1 [patent_app_number] => 8/467975 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9384 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985641.pdf [firstpage_image] =>[orig_patent_app_number] => 467975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4011049 [patent_doc_number] => 05889158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Methods and kits for the detection of human immunodeficiency virus type 2 employing HIV-2 specific antibodies and antigens' [patent_app_type] => 1 [patent_app_number] => 8/466704 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4972 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889158.pdf [firstpage_image] =>[orig_patent_app_number] => 466704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4060529 [patent_doc_number] => 05866320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Nucleic acids encoding for non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region' [patent_app_type] => 1 [patent_app_number] => 8/470419 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9825 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866320.pdf [firstpage_image] =>[orig_patent_app_number] => 470419 [rel_patent_id] =>[rel_patent_doc_number] =>)